Marksans Pharma Ltd MARKSANS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:27 PM IST
56.05quote price arrow up+0.50 (+0.90%)
Volume
1,770,911
52 week range
9.85 - 66.20

...

Loading . . .

KEY STATS

  • Open56.10
  • Day High58.00
  • Day Low55.55
  • Prev Close55.55
  • 52 Week High66.20
  • 52 Week High Date12/07/20
  • 52 Week Low9.85
  • 52 Week Low Date03/24/20
  • Market Cap308.09M
  • Shares Out409.31M
  • 10 Day Average Volume904,729
  • Dividend0.10
  • Dividend Yield0.18%
  • Beta
  • 1 Year % Change231.66

RATIOS/PROFITABILITY

  • EPS (TTM)4.83
  • P/E (TTM)11.61
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2020
  • Div Amount0.10
  • Split Date-
  • Split Factor-

Latest Marksans Pharma Ltd News

There is no recent news for this security.

Latest MARKSANS-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous. The Company undertakes research and development initiatives, and offers...
Mark Saldanha
Chairman
Address
21 Lotus Business Park
, Off New Link Road,, Andheri (W)
Mumbai
400053
India